Delivery Order SPE2DB20D3303-SPE2DB24FZ8W3

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, which has a total potential value of $4,847.35, is a Delivery Order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,455.36 and an ultimate completion date of April 18, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products, specifically Fluticasone-Salmeterol 115-21 12GM, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,298.98 and is a firm fixed-price delivery order that runs through June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is a $3,394.44 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which does not have a set-aside designation, is for the supply of the pharmaceutical product "FLUTICASONE-SALMETEROL 115-21 12GM." This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of fluticasone-salmeterol 115-21 12GM to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $3,490.44, has an ultimate completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products. The contract, valued at $3,057.35, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a major defense agency. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical product to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,206.80 and is a firm fixed price delivery order that runs through May 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award, valued at $12,034.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for Firm Fixed Price and covers the provision of Fluticasone-Salmeterol 230-21 12GM pharmaceutical products. AmerisourceBergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $2,725.20, is a Delivery Order for the supply of the pharmaceutical product Fluticasone-Salmeterol 45-21 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This federal contract award is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The total ceiling value of the contract is $12,309.58, and it is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ8W3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order with a ceiling value of $14,029.50. The contract is for the supply of a specific pharmaceutical product, Fluticasone-Salmeterol 230-21 12GM, to the Defense Logistics Agency (DLA).

The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/2/24, 3:37 PM